Its pouring down here in the Lake district, but here’s some virtual NGAL sunshine for the weekend.

its been a splendid summer so far… US ratio patent, new regional distributor in Latin America, clear verdict in the Phadia vs BioPorto case (even if appealed).

The only thing missing so far – is the Global Distributor Agreement that we are expecting any week now… It could be imminent, or rather, I’m sure its imminent; and one of the reasons is this:–Key-Account-Manager-Gentofte-Bioporto-Diagnostics-A-S–341321-inline.html

Isn’t that just another recruitment ad ? you might say…. ahhh, it is, it is- but in this case, I recall remarks by CEO Thea Olesen when I asked her some time ago about additional beefing up of the sales organisation  —

“I won’t do that until I’m dead certain that there are Significant Clients enough to pay for them” she said, and continued “No use in putting additional strain on our liquidity.”

So the obvious conclusion is ????

Yep – distribution agreement might just be around the corner…

AACC’s in L.A. in just one week


About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂


Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.